Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progressionMartin Jädersten, Leonie Saft, Alexander Smith, et al.
Oncoscience|January 17, 2015
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological featuresAgata M Wasik, Lina Nygren, Stefan Almestrand, et al.
Cytometry. Part B, Clinical Cytometry|February 18, 2022
A series of case studies illustrating the role of flow cytometry in the diagnostic work-up of myelodysplastic syndromesTheresia M Westers, Leonie Saft, Vincent H J van der Velden, et al.
Blood|June 22, 2017
<i>SF3B1</i>-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cellsTeresa Mortera-Blanco, Marios Dimitriou, Petter S Woll, et al.
American Journal of Clinical Pathology|December 28, 2020
Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline DisordersKatalin Kelemen, Leonie Saft, Fiona E Craig, et al.
Leukemia & Lymphoma|October 24, 2019
Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemiaIngegerd Ivanov Öfverholm, Vasilios Zachariadis, Fulya Taylan, et al.
Haematologica|November 26, 2016
Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutationsChristian Scharenberg, Valentina Giai, Andrea Pellagatti, et al.
Haematologica|February 9, 2012
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET studyMatteo G Della Porta, Cristina Picone, Cristiana Pascutto, et al.
Ejhaem|December 18, 2025
Development of Machine-Assisted, Human-Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic SyndromesKiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, et al.
Haematologica|April 1, 2014
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)Leonie Saft, Mohsen Karimi, Mehran Ghaderi, et al.
Pageof 4